At Chrysalis Skin & Scars, Metabolic Optimization Therapy utilizes GLP-1 receptor agonist medications as part of a structured, medically supervised approach to metabolic regulation and weight management.

GLP-1 (glucagon-like peptide-1) is a naturally occurring hormone involved in appetite regulation, insulin signaling, and metabolic balance. Therapeutic GLP-1 modulation works by enhancing satiety signaling, slowing gastric emptying, and supporting improved glycemic control — helping patients reduce caloric intake in a physiologically guided manner.

Our focus is not rapid cosmetic weight loss.
It is metabolic stabilization and structured body transformation.

GLP-1 therapy may be appropriate for individuals experiencing:

Metabolic resistance or plateaued weight loss
Insulin sensitivity challenges
Central adiposity
Hormonal weight fluctuations
Weight-related inflammatory burden

Each program begins with a comprehensive medical evaluation, including metabolic history, lifestyle factors, and individualized risk assessment. Dosing is carefully titrated and monitored to prioritize safety, tolerability, and long-term sustainability.

Because rapid weight reduction can impact collagen integrity and skin elasticity, our metabolic programs are often integrated with regenerative skin and tissue support therapies. This allows us to address not only systemic metabolic function but also structural skin health during body transformation.

This is not a trend-driven approach.
It is clinically guided metabolic support.

At Chrysalis, GLP-1 therapy is positioned within a broader regenerative framework — helping patients optimize internal metabolic function while maintaining tissue integrity, structural resilience, and overall well-being.

‹ UltraClear® Laser

Targeted Cellular Optimization ›